The description of antiphospholipid syndrome (APS) is vascular thrombosis and/or
pregnancy morbidity occurring in persons with antiphospholipid antibodies (aPL). However …

Antiphospholipid antibody syndrome (APS) is an autoimmune acquired thrombophilia
characterized by recurrent thrombosis and pregnancy morbidity in the presence of …

The antiphospholipid antibody syndrome (APS) is recognized as a major cause of acquired
thrombophilia and recurrent pregnancy morbidity. 6, 9, 11, 12, 19 It can either occur as a free …

The antiphospholipid syndrome (APS) is the most common acquired thrombophilia. It is
characterized by venous and arterial thrombosis, recurrent pregnancy loss, and various …

The antiphospholipid syndrome (APS) is an autoimmune disorder characterized by the
occurrence of venous and arterial thromboses, often multiple, and obstetric-related adverse …

Antiphospholipid syndrome is a systemic autoimmune disorder characterized by vascular
thrombosis and/or obstetric events in association with persistently elevated antiphospholipid …

Opinion statement Antiphospholipid antibody syndrome (APS) is a recently defined
autoimmune disorder characterized by recurrent vascular thromboses or recurrent …

Antiphospholipid syndrome (APS) is characterized by antiphospholipid antibodies (aPL)
associated with thrombosis and/or pregnancy morbidity. However, there is a range of other …

The antiphospholipid syndrome (APS) was fully recognized as a clinical entity in the early
1980s. Still, more than 30 years later, the epidemiology of APS is not well described, and …

Antiphospholipid antibody syndrome (APS) is a systemic autoimmune disease with
thrombotic predilection resulting in vascular thrombotic events and obstetric complications …